DJ
Dr Jeannie Lee BOARD MEMBER
Insider track record Other Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Dr Jeannie Lee. Officer active across 1 company, notably GSK plc. Aggregated, 18 filings have been recorded. History available since 20 June 2024. The latest transaction was disclosed on 22 June 2026 (Purchase). Regulator: RNS (LSE). The full history is openly available.
Declarations 18 total
● Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 802 shares @ £50.6908 0.0001% mcap 96.8% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:9632737-5 Ideal exit: 19 Mar 2027 (T+270) ● Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 802 shares @ £0.5069 0.0000% mcap 30.2% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-5 Ideal exit: 19 Mar 2027 (T+270) ● Independent Non-Executive Director · Executives · 9 Apr 2026 · GSK plc 14 shares @ £0.5893 0.0000% mcap 0.9% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-15 Ideal exit: 4 Jan 2027 (T+270) ● Independent Non-Executive Director · Executives · 20 Mar 2026 · GSK plc 195 shares @ £0.5179 0.0000% mcap 10.9% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-6 Ideal exit: 15 Dec 2026 (T+270) ● Independent Non-Executive Director · Executives · 9 Jan 2026 · GSK plc 13 shares @ £0.5046 0.7% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-39 Ideal exit: 6 Oct 2026 (T+270) ● Independent Non-Executive Director · Executives · 19 Dec 2025 · GSK plc 202 shares @ £0.4855 10.4% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-5 Ideal exit: 15 Sept 2026 (T+270) ● Independent Non-Executive Director · Executives · 10 Oct 2025 · GSK plc 13 shares @ £0.4377 0.8% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5859068-30 Ideal exit: 7 Jul 2026 (T+270) ● Independent Non-Executive Director · Executives · 19 Sept 2025 · GSK plc 239 shares @ £0.4074 13.4% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5830475-6 Ideal exit: 16 Jun 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Jul 2025 · GSK plc 11 shares @ £0.3855 0.6% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5737340-37 Ideal exit: 7 Apr 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 258 shares @ £0.379 16.0% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5708028-7 Ideal exit: 17 Mar 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 258 shares @ £0.379 16.0% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5707630-7 Ideal exit: 17 Mar 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Apr 2025 · GSK plc 10 shares @ £0.341 0.6% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5617047-6 Ideal exit: 6 Jan 2026 (T+270) ● Independent Non-Executive Director · Executives · 20 Mar 2025 · GSK plc 249 shares @ £0.3927 24.2% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5584787-8 Ideal exit: 15 Dec 2025 (T+270) ● Independent Non-Executive Director · Executives · 10 Jan 2025 · GSK plc 6 shares @ £0.3333 0.5% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5498728-22 Ideal exit: 7 Oct 2025 (T+270) ● Independent Non-Executive Director · Executives · 20 Dec 2024 · GSK plc 271 shares @ £0.3381 22.9% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5479029-8 Ideal exit: 16 Sept 2025 (T+270) ● Independent Non-Executive Director · Executives · 11 Oct 2024 · GSK plc 2 shares @ £0.39 0.4% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5388451-6 Ideal exit: 8 Jul 2025 (T+270) ● Independent Non-Executive Director · Executives · 23 Sept 2024 · GSK plc 224 shares @ £0.4101 43.7% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5362280-7 Ideal exit: 20 Jun 2025 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2024 · GSK plc 293 shares @ £0.4076 100.0% of flow New York Stock Exchange (XNYS)US37733W2044⌘ RNS:5235239-7 Ideal exit: 17 Mar 2025 (T+270) About Dr Jeannie Lee Dr Jeannie Lee is an Independent Non-Executive Director at GSK plc. She has 18 filings in total, and across the sampled recent filings from 2024-06-21 to 2026-06-24, purchases amount to EUR 48394 and sales to EUR 0, with the modal transaction nature listed as Purchase.